Objective: To use molecular genetic techniques to prenatally screen for ani
ridia.
Design: Case report.
Methods: DNA was extracted from cultured fibroblasts obtained through amnio
centesis. Two mutation detection methods, Ava1 restriction digestion and si
ngle-strand conformational polymorphism electrophoresis, were used to scree
n the PAX6 gene.
Main Outcome Measurer The results from the amniocentesis sample were compar
ed with DNA obtained from the affected father, firstborn infant, and unaffe
cted mother to determine whether the fetus carried the PAX6 mutation.
Results: DNA from the fetus demonstrated the same banding pattern as the af
fected father and firstborn infant.
Conclusions: The fetus carried the mutated PAX6 allele and was predicted to
develop aniridia. This was later confirmed when the child was born. This c
ase report illustrates an important use of genetic mutation screening in th
e clinical setting. Ophthalmology 2000; 107:1153-1156 (C) 2000 by the Ameri
can Academy of Ophthalmology.